| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tilray Inc (NASDAQ: TLRY)
TLRY Technical Analysis
5
| As on 9th Jun 2023 TLRY STOCK Price closed @ 1.59 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.75 & Strong Sell for SHORT-TERM with Stoploss of 6.53 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TLRYSTOCK Price
| Open | 1.68 | Change | Price | % |
| High | 1.68 | 1 Day | -0.08 | -4.79 |
| Low | 1.58 | 1 Week | -0.27 | -14.52 |
| Close | 1.59 | 1 Month | -0.65 | -29.02 |
| Volume | 21001428 | 1 Year | -6.39 | -80.08 |
| 52 Week High 8.56 | 52 Week Low 1.67 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TLRY Daily Charts |
TLRY Intraday Charts |
Whats New @ Bazaartrend |
TLRY Free Analysis |
|
|
TLRY Important Levels Intraday
| RESISTANCE | 1.78 |
| RESISTANCE | 1.72 |
| RESISTANCE | 1.68 |
| RESISTANCE | 1.64 |
| SUPPORT | 1.54 |
| SUPPORT | 1.50 |
| SUPPORT | 1.46 |
| SUPPORT | 1.40 |
TLRY Forecast April 2024
| 4th UP Forecast | 6.77 |
| 3rd UP Forecast | 5.11 |
| 2nd UP Forecast | 4.08 |
| 1st UP Forecast | 3.06 |
| 1st DOWN Forecast | 0.12 |
| 2nd DOWN Forecast | -0.9 |
| 3rd DOWN Forecast | -1.93 |
| 4th DOWN Forecast | -3.59 |
TLRY Weekly Forecast
| 4th UP Forecast | 3.50 |
| 3rd UP Forecast | 2.89 |
| 2nd UP Forecast | 2.51 |
| 1st UP Forecast | 2.13 |
| 1st DOWN Forecast | 1.05 |
| 2nd DOWN Forecast | 0.67 |
| 3rd DOWN Forecast | 0.29 |
| 4th DOWN Forecast | -0.32 |
TLRY Forecast2024
| 4th UP Forecast | 16.04 |
| 3rd UP Forecast | 11.41 |
| 2nd UP Forecast | 8.54 |
| 1st UP Forecast | 5.68 |
| 1st DOWN Forecast | -2.5 |
| 2nd DOWN Forecast | -5.36 |
| 3rd DOWN Forecast | -8.23 |
| 4th DOWN Forecast | -12.86 |
Tilray Inc ( NASDAQ USA Symbol : TLRY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TLRY Business Profile
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York. Address: 655 Madison Avenue, New York, NY, United States, 10065
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service